FDA Panel Backs Pfizer's RSV Vaccine for Older Adults

(MedPage Today) -- In two somewhat close votes, an FDA panel of outside experts recommended the agency approve Pfizer's respiratory syncytial virus (RSV) vaccine for older adults, despite concerns over the potential risk for Guillain Barré...
Source: MedPage Today Primary Care - Category: Primary Care Source Type: news